
    
      Phase 1: Single center, open Phase 2a : Multi-center, randomized, double-blind, parallel,
      placebo Clinical Trial to Evaluate the Efficacy and Safety of FURESTEM-RA Inj. for Moderate
      to Severe Rheumatoid arthritis
    
  